Other Clinical Trial - Clinical Study of QingReMoShen Granule to Treat

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06245707` - the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy	N/A
Recruiting	`NCT03864250` - Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy	N/A
Completed	`NCT01180036` - MEmbranous Nephropathy Trial Of Rituximab	Phase 2/Phase 3
Withdrawn	`NCT01093781` - Aliskiren in Patients With Idiopathic Membranous Nephropathy	N/A
Completed	`NCT00362531` - Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome	Phase 2/Phase 3
Recruiting	`NCT05839314` - Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy	Phase 4
Completed	`NCT00302523` - Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy	N/A
Terminated	`NCT03466801` - The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.	N/A
Terminated	`NCT03475602` - Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy
Not yet recruiting	`NCT05850845` - Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMN
Not yet recruiting	`NCT05667909` - Prognostic Model of Rituximab in the Treatment of MN
Not yet recruiting	`NCT05667883` - Prognostic Model of GC/CTX in the Treatment of MN
Not yet recruiting	`NCT05667896` - Prognostic Model of GC/TAC in the Treatment of MN
Not yet recruiting	`NCT05667922` - Prognostic Model of TAC in the Treatment of MN
Recruiting	`NCT02173106` - A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy	Phase 2
Completed	`NCT01161459` - Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid	N/A
Recruiting	`NCT03549663` - Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)	N/A
Not yet recruiting	`NCT05845762` - Obinutuzumab in the Management of Idiopathic Membranous Nephropathy
Completed	`NCT00694863` - Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy	Phase 2
Recruiting	`NCT03170323` - Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy	Phase 4

NCT number	NCT01845688
Study type	Interventional
Source	Shanghai University of Traditional Chinese Medicine
Contact
Status	Completed
Phase	N/A
Start date	November 2011
Completion date	September 2016

Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms